Medium materiality6/10
Berenberg Upgrades GlaxoSmithKline (GSK) to Buy
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
GSK upgraded to Buy; target $60; current price $50.05 (Berenberg Bank).
- Upgrade to Buy; target above current price.
Key facts
- 01
Target: $60
- 02
Posted price: $50.05
- 03
Analyst firm: Berenberg Bank
- 04
Analyst: Kerry Holford
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.